↓ Skip to main content

Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis

Overview of attention for article published in Immunologic Research, April 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#33 of 950)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
twitter
69 X users
facebook
4 Facebook pages

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
77 Mendeley
citeulike
1 CiteULike
Title
Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis
Published in
Immunologic Research, April 2013
DOI 10.1007/s12026-013-8413-z
Pubmed ID
Authors

Amy D. Proal, Paul J. Albert, Trevor G. Marshall, Greg P. Blaney, Inge A. Lindseth

Abstract

Chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) has long been associated with the presence of infectious agents, but no single pathogen has been reliably identified in all patients with the disease. Recent studies using metagenomic techniques have demonstrated the presence of thousands of microbes in the human body that were previously undetected and unknown to science. More importantly, such species interact together by sharing genes and genetic function within communities. It follows that searching for a singular pathogen may greatly underestimate the microbial complexity potentially driving a complex disease like CFS/ME. Intracellular microbes alter the expression of human genes in order to facilitate their survival. We have put forth a model describing how multiple species-bacterial, viral, and fungal-can cumulatively dysregulate expression by the VDR nuclear receptor in order to survive and thus drive a disease process. Based on this model, we have developed an immunostimulatory therapy that is showing promise inducing both subjective and objective improvement in patients suffering from CFS/ME.

X Demographics

X Demographics

The data shown below were collected from the profiles of 69 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
United States 2 3%
United Kingdom 1 1%
Unknown 72 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 22%
Student > Master 13 17%
Student > Bachelor 9 12%
Student > Ph. D. Student 7 9%
Student > Postgraduate 7 9%
Other 10 13%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 21 27%
Agricultural and Biological Sciences 8 10%
Nursing and Health Professions 7 9%
Biochemistry, Genetics and Molecular Biology 7 9%
Psychology 5 6%
Other 13 17%
Unknown 16 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#933,959
of 25,708,267 outputs
Outputs from Immunologic Research
#33
of 950 outputs
Outputs of similar age
#6,654
of 213,264 outputs
Outputs of similar age from Immunologic Research
#5
of 21 outputs
Altmetric has tracked 25,708,267 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 950 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.